WELL trades against a final fair-value range of $56.34-$78.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $56.3, high $78.6, with mid-point at $65.8.
Este relatório ainda não foi traduzido. Atualize em alguns minutos assim que a fila de tradução recuperar o atraso.
§1 Resumo executivo
Composite fair value $66 with high case $79.
Implied downside of 69.3% to fair value.
Moat 6.5/10 · confidence 88/100 · REIT.
Currently screens above fair value, so patience matters more than entry speed.
Fair value
$66
Margin of safety
-226.2%
Confidence
88/100
Moat
6.5/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$214.63Price
Low $56.34
Mid $65.79
High $78.60
WELL trades against a final fair-value range of $56.34-$78.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
Unmatched real estate portfolio in
Unmatched real estate portfolio in highly attractive, high-barrier micro-markets.
Data Science platform enabling highly
Data Science platform enabling highly disciplined capital allocation.
Cycle upside
Unprecedented demand driven by the aging 'silver tsunami' outstripping new senior housing supply.
§2 Cenário pessimista
A sustained high-interest-rate environment coupled with sticky healthcare labor inflation would severely constrain accretive acquisitions while crushing property-level operating margins, driving valuation sharply toward the $56.34 low.
Como esta tese pode falhar
Cost of Capital Blowout
· Medium
Prolonged high interest rates severely limit accretive acquisition volume and compress real estate cap rates across the sector.
FV impact
Severe downside to $56.34
Trigger
12-24 months
Structural Labor Squeeze
· Medium
Persistent shortages in healthcare staffing drive runaway wage inflation, permanently squeezing operator margins and reducing AFFO generation.
FV impact
Moderate downside
Trigger
24-36 months
Demographic Supply Glut
· Low
Competitors massively overbuild in key micro-markets ahead of the aging wave, crushing occupancy and pricing power.
FV impact
Minor downside
Trigger
3-5 years
Sinais de alerta antecipado para monitorar
Métrica
Atual
Limite de gatilho
Decelerating or negative sequential AFFO per share growth.
Monitor
Deterioration versus the report thesis
Stalling occupancy rate recovery across the core premium senior housing portfolio.
Monitor
Deterioration versus the report thesis
Narrowing investment spreads between implied cap rates and marginal cost of debt.
Monitor
Deterioration versus the report thesis
Surging operator labor costs per occupied unit compressing site-level EBITDAR.
Monitor
Deterioration versus the report thesis
Multiple expansion on recently closed asset sales indicating market exhaustion.
Monitor
Deterioration versus the report thesis
§3 Histórico financeiro
Demonstração de resultados — últimos seis períodos
Free cash flow for WELL (WELL) is computed as operating cash flow minus capital expenditure. We report both the absolute level and the FCF margin against revenue, with five years of trajectory.
Operating cash flow is the primary signal: when OCF is negative or significantly below net income, the cash-flow subsection flags the divergence and traces the cause to working-capital, deferred-revenue, or earnings-quality effects.
Capital expenditure is reported as a percentage of revenue alongside the absolute number. Heavy investment phases are separated from harvesting phases so reinvestment intent is legible.
The financing activity row tracks dividends paid, share repurchases, and net debt issuance. Together with FCF, it answers whether buybacks and dividends are funded organically or by issuing debt.
FAQ
WELL — frequently asked questions
Based on our latest analysis, WELL looks meaningfully overvalued. The current price is $215 versus a composite fair-value midpoint of $65.8 (range $56.3–$78.6), which implies roughly 69.3% downside to the midpoint.
Our composite fair-value range for WELL is $56.3–$78.6, with a midpoint of $65.8. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for WELL's archetype.
Our current rating for WELL is Sell with a confidence score of 88/100. WELL is rated Sell at $214.63 versus the reconciled fair value midpoint of $65.79, implying -69.35% upside/downside. Confidence is separately disclosed at 88/100. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for WELL are: Cost of Capital Blowout; Structural Labor Squeeze; Demographic Supply Glut. The single biggest risk is Cost of Capital Blowout: Prolonged high interest rates severely limit accretive acquisition volume and compress real estate cap rates across the sector.
Our current rating for WELL is Sell, issued with a confidence score of 88/100 and a moat score of 6.5/10. The rating reflects the composite fair-value range ($56.3–$78.6) versus the current price of $215.
WELL is classified as a REIT stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for WELL.
